People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seres Health, Inc. | — | Pharmaceuticals | Series C | $123.6M | $2.3B | 2014 |
Lorence Barton Kim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lorence Barton Kim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barton Hutt | 1 | 14 |
| Noubar Afeyan | 1 | 9 |
| Werner Cautreels | 1 | 5 |
| Roger J. Pomerantz | 1 | 4 |
| Roger Pomerantz | 1 | 4 |
| David Berry | 1 | 3 |
| David J. Berry | 1 | 2 |
| Greg D. Behar | 1 | 1 |
| Richard Barton Kender | 1 | 1 |
| Werner J. Cautreels | 1 | 1 |
| Noubar J. Afeyan | 1 | 1 |
| John D. Aunins | 1 | 1 |
| Eric D. Shaff | 1 | 1 |
| David D. Cook | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.